Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Heart Closure Devices Market

ID: MRFR/HC/65111-HCR
200 Pages
Satyendra Maurya
December 2024

Heart Closure Devices Market Research Report: Size, Share, and Trend Analysis by End User Outlook (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Specialty Clinics, Research Institutions), by Material Outlook (Metal, Polymer, Biodegradable Materials, Composite Materials, Ceramics), by Technology Outlook (Minimally Invasive Techniques, Robotic Surgery, 3D Imaging, Ultrasound Guidance, Electrophysiology), by Application Outlook (Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Left Atrial Appendage Closure, Congenital Heart Defects), by Device Type Outlook (Transcatheter Closure Devices, Surgical Closure Devices, Occluders, Patches, Stents), and by Region (North America, Europe, South America, Asia Pacific, Middle East & Africa) – Growth Outlook & Industry Forecast, 2025 to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

heart closure devices market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Heart Closure Devices Market Summary

As per MRFR analysis, the Heart Closure Devices market size was estimated at 4.5 USD Billion in 2024. The heart closure devices industry is projected to grow from 4.74 USD Billion in 2025 to 8.0 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.37% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The heart closure devices market is experiencing robust growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • North America remains the largest market for heart closure devices, driven by advanced healthcare infrastructure and high patient awareness.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and a growing geriatric population.
  • Atrial septal defect closure devices dominate the market, while left atrial appendage closure devices are witnessing the fastest growth due to increasing atrial fibrillation cases.
  • Rising incidence of cardiovascular diseases and technological innovations in device design are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 4.5 (USD Billion)
2035 Market Size 8.0 (USD Billion)
CAGR (2025 - 2035) 5.37%

Major Players

Abbott (US), Boston Scientific (US), Medtronic (US), Edwards Lifesciences (US), Terumo Corporation (JP), LivaNova (GB), AtriCure (US), Cardia (US), W. L. Gore & Associates (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Heart Closure Devices Market Trends

The heart closure devices market is currently experiencing a transformative phase characterized by advancements in technology and increasing awareness regarding cardiovascular health. Innovations in device design and materials are enhancing the efficacy and safety of these products, which are primarily utilized to treat conditions such as atrial septal defects and patent foramen ovale. The growing prevalence of heart-related ailments is driving demand, as healthcare providers seek effective solutions to improve patient outcomes. Furthermore, the integration of minimally invasive techniques is reshaping surgical approaches, making procedures less traumatic for patients and potentially reducing recovery times. In addition to technological advancements, the heart closure devices Market is witnessing a shift towards personalized medicine. Tailoring treatments to individual patient needs appears to be gaining traction, as healthcare professionals recognize the importance of customized solutions in enhancing therapeutic effectiveness. Regulatory bodies are also playing a crucial role in ensuring the safety and efficacy of these devices, which may lead to increased confidence among healthcare providers and patients alike. Overall, the heart closure devices Market is poised for growth, driven by innovation, patient-centric approaches, and a commitment to improving cardiovascular health outcomes.

Technological Advancements

The heart closure devices Market is seeing rapid technological progress, with new materials and designs enhancing device performance. Innovations such as bioresorbable materials and advanced imaging techniques are likely to improve procedural outcomes and patient safety.

Minimally Invasive Procedures

There is a noticeable trend towards minimally invasive techniques in the heart closure devices Market. These approaches reduce surgical trauma, leading to shorter recovery times and less postoperative discomfort for patients, which may increase their appeal.

Personalized Medicine

The shift towards personalized medicine is becoming more pronounced within the heart closure devices Market. Tailoring interventions to individual patient profiles could enhance treatment effectiveness and patient satisfaction, reflecting a broader trend in healthcare.

Heart Closure Devices Market Drivers

Growing Geriatric Population

The rise in the geriatric population is a significant factor driving the heart closure devices Market. As individuals age, the incidence of cardiovascular diseases tends to increase, necessitating effective treatment options. The demographic shift towards an older population is prompting healthcare providers to seek solutions that cater specifically to this group. Market analysis indicates that the demand for heart closure devices is expected to grow in tandem with the aging population, as these devices offer less invasive alternatives that align with the preferences of older patients. This trend underscores the importance of developing heart closure devices that are tailored to meet the unique needs of geriatric patients.

Government Initiatives and Funding

Government initiatives aimed at improving cardiovascular health are influencing the heart closure devices Market. Many countries are implementing policies that promote research, development, and accessibility of advanced medical technologies. Funding for cardiovascular health programs has increased, allowing for greater investment in innovative heart closure devices. This support not only facilitates the development of new products but also enhances the distribution of existing devices, making them more accessible to patients in need. As governments recognize the economic burden of untreated cardiovascular diseases, the focus on preventive measures and effective treatments is likely to bolster the heart closure devices Market.

Technological Innovations in Device Design

Technological advancements play a crucial role in shaping the heart closure devices Market. Innovations in materials and design have led to the development of devices that are not only more effective but also safer for patients. For instance, the introduction of bioresorbable materials and advanced imaging techniques has enhanced the precision of device placement, reducing the risk of complications. Market data indicates that the heart closure devices segment is expected to witness significant growth, driven by these innovations. As manufacturers invest in research and development, the availability of cutting-edge devices is likely to expand, catering to a broader range of patient needs and preferences.

Increasing Awareness and Screening Programs

The growing awareness of heart health and the implementation of screening programs are contributing to the expansion of the heart closure devices Market. Educational initiatives aimed at both healthcare professionals and the public have led to earlier detection of cardiovascular conditions, which in turn drives demand for heart closure devices. Data suggests that regions with robust screening programs report higher rates of diagnosis and subsequent treatment, including the use of heart closure devices. This trend indicates a shift towards proactive healthcare, where early intervention can significantly improve patient outcomes and reduce long-term healthcare costs.

Rising Incidence of Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases is a primary driver for the heart closure devices Market. As populations age and lifestyle-related health issues become more common, the demand for effective treatment options rises. According to recent data, cardiovascular diseases account for a substantial percentage of global mortality, prompting healthcare systems to seek innovative solutions. Heart closure devices, which are designed to treat conditions such as atrial septal defects and patent foramen ovale, are gaining traction as they offer less invasive alternatives to traditional surgical methods. This trend is likely to continue, as healthcare providers aim to improve patient outcomes while managing costs associated with cardiovascular care.

Market Segment Insights

By Application: Atrial Septal Defect (Largest) vs. Left Atrial Appendage Closure (Fastest-Growing)

In the heart closure devices market, the application segment showcases a diverse distribution among key values such as Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Left Atrial Appendage Closure, and Congenital Heart Defects. Atrial Septal Defect currently holds the largest share due to its prevalence and established treatment protocols, while Left Atrial Appendage Closure is noted for its rapid growth, driven by increased awareness and advancements in minimally invasive techniques. Meanwhile, Patent Foramen Ovale and Ventricular Septal Defect demonstrate steady demand as physicians enhance their focus on personalized patient care. Growth trends within the heart closure devices market are influenced by several factors contributing to the popularity of specific applications. The increasing incidence of congenital heart defects and the aging population are significant drivers, leading to heightened demand for effective treatment options. Moreover, technological advancements and the introduction of innovative devices are propelling the market forward. Additionally, educational initiatives and improved diagnostic capabilities are generating awareness about the benefits of heart closure devices, particularly the efficacy of Left Atrial Appendage Closure, suggesting a robust upward trajectory for this segment in the upcoming years.

Atrial Septal Defect (Dominant) vs. Left Atrial Appendage Closure (Emerging)

Atrial Septal Defect (ASD) remains the dominant application in the heart closure devices market owing to its widespread recognition and successful treatment outcomes. The procedures associated with ASD have been refined over the years, leading to better patient experiences and recovery times. On the other hand, Left Atrial Appendage Closure (LAAC) is emerging as a vital application due to its unique role in preventing stroke in patients with atrial fibrillation. LAAC devices have gained traction, underscoring their potential to cater to a niche but critical patient population. While ASD procedures are well-established, the innovative landscape surrounding LAAC is driving its adoption, indicating a significant shift in focus towards preventive cardiac interventions.

By Device Type: Transcatheter Closure Devices (Largest) vs. Surgical Closure Devices (Fastest-Growing)

The heart closure devices market is primarily segmented into transcatheter closure devices, surgical closure devices, occluders, patches, and stents, with transcatheter closure devices leading the market. This segment has garnered significant attention due to its minimally invasive technique, allowing for reduced recovery times and lower complication risks. Following this, surgical closure devices are gaining momentum, particularly in specific patient demographics where traditional methods are still preferred. The combined share of occluders, patches, and stents, while considerable, remains overshadowed by these two prominent segments.

Closure Technology: Transcatheter Occluders (Dominant) vs. Surgical Patches (Emerging)

Transcatheter occluders represent the dominant segment within heart closure devices, characterized by their ability to be deployed via catheterization, offering minimally invasive options for patients with various cardiac anomalies. Their effectiveness in addressing septal defects and patent foramen ovale positions them as a preferred choice among healthcare providers and patients alike. In contrast, surgical patches are emerging as a viable alternative for larger defects that require more robust intervention. While not as prevalent as transcatheter devices, their importance in surgical procedures and adaptability to several patient needs suggest a growing role in the market, especially in regions where surgical intervention remains the standard practice.

By End User: Hospitals (Largest) vs. Cardiac Centers (Fastest-Growing)

Hospitals hold a significant share of the heart closure devices market, serving as the primary facilities for cardiac procedures. Their extensive resources, specialized staff, and advanced infrastructure enable them to perform complex surgeries, which contributes to their leading position in device usage. Cardiac centers are gaining traction, increasingly focusing on specific heart-related conditions and interventions. This trend is reshaping the landscape, as these centers become focal points for specialized care.

Hospitals (Dominant) vs. Cardiac Centers (Emerging)

Hospitals are the dominant end users of heart closure devices, equipped with comprehensive surgical suites and multidisciplinary teams to handle a wide range of cardiac complications. Their established patient bases and ability to invest in cutting-edge technologies solidify their market leadership. On the other hand, cardiac centers are emerging as vital players, focusing solely on cardiac care, which allows for enhanced expertise and efficiency in heart interventions. Their growth is driven by an increase in elective surgeries and a shift toward specialized treatments, making them a key focus for future advancements in heart closure technology.

By Material: Metal (Largest) vs. Polymer (Fastest-Growing)

The heart closure devices market showcases a diverse material segment, where metal materials dominate due to their strong mechanical properties and long-standing use in the industry. Metal closure devices, including stainless steel and titanium, hold a significant market share, reflecting their reliability and effectiveness in medical applications. However, polymers are gaining traction rapidly, attributed to their lightweight nature and biocompatibility, indicating a shift towards more innovative material alternatives in the market.

Metal (Dominant) vs. Polymer (Emerging)

Metal materials, particularly stainless steel and titanium, have established themselves as the dominant choice in heart closure devices due to their robust mechanical strength, resistance to corrosion, and ease of sterilization. They offer long-term durability and support crucial applications in cardiac surgeries. On the other hand, polymer-based heart closure devices are emerging as a competitive alternative, providing excellent flexibility and reducing the overall weight of devices, which is crucial for minimally invasive procedures. Their biocompatibility and adaptability to design innovations make them attractive options, driving increasing adoption rates, especially in regions focusing on advanced cardiac interventions.

By Technology: Minimally Invasive Techniques (Largest) vs. Robotic Surgery (Fastest-Growing)

In the heart closure devices market, minimally invasive techniques dominate the technology segment due to their widespread adoption for various cardiac procedures. These techniques have significantly improved patient outcomes, leading to a favorable market share that outpaces other modalities. Robotic surgery, while currently smaller, is rapidly gaining ground due to its precision and the added benefits it offers to both surgeons and patients.

Technology: Minimally Invasive Techniques (Dominant) vs. Robotic Surgery (Emerging)

Minimally invasive techniques have solidified their position as the dominant technology in heart closure devices, primarily due to their ability to reduce recovery times and minimize surgical trauma. This segment encompasses a range of procedures that allow for smaller incisions and enhanced patient comfort. Conversely, robotic surgery is emerging rapidly, showcasing advanced capabilities like enhanced visualization and dexterity. As healthcare providers seek innovative solutions for complex cardiac procedures, the rise of robotic surgery is expected to transform the landscape, signifying a shift towards more accurate and efficient surgical methods that could redefine patient care.

Get more detailed insights about Heart Closure Devices Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the heart closure devices market, holding a significant share of 2.25 billion in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on innovative medical technologies. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring that new devices meet stringent safety and efficacy standards. The competitive landscape in North America is robust, featuring key players such as Abbott, Boston Scientific, and Medtronic. These companies are at the forefront of technological advancements, offering a range of heart closure devices that cater to diverse patient needs. The presence of established healthcare systems and a high level of investment in R&D contribute to the region's dominance, making it a hub for medical device innovation.

Europe : Emerging Market with Growth Potential

Europe's heart closure devices market is valued at 1.5 billion, reflecting a growing demand driven by an aging population and rising awareness of cardiovascular health. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing market dynamics by ensuring high safety standards. The region is witnessing an increase in minimally invasive procedures, which is further propelling market growth and adoption of advanced heart closure technologies. Leading countries in Europe include Germany, France, and the UK, where healthcare investments are substantial. Major players like Edwards Lifesciences and LivaNova are actively expanding their product offerings to meet the rising demand. The competitive landscape is characterized by innovation and strategic partnerships, positioning Europe as a key player in The heart closure devices.

Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific heart closure devices market, valued at 0.9 billion, is experiencing rapid growth due to increasing healthcare expenditure and a rising prevalence of heart diseases. Countries like China and India are witnessing significant investments in healthcare infrastructure, which is driving demand for advanced medical devices. Regulatory bodies are also becoming more supportive, facilitating quicker approvals for innovative products, thus enhancing market accessibility. In this region, key players such as Terumo Corporation and AtriCure are expanding their presence to capitalize on the growing market. The competitive landscape is evolving, with local manufacturers emerging alongside established global companies. This dynamic environment is expected to foster innovation and improve patient outcomes in heart closure procedures.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa heart closure devices market is valued at 0.35 billion, representing significant untapped potential. The region is witnessing a gradual increase in healthcare investments, driven by government initiatives aimed at improving healthcare access and quality. The rising prevalence of cardiovascular diseases is prompting healthcare providers to adopt advanced medical technologies, including heart closure devices, to enhance patient care. Countries like South Africa and the UAE are leading the way in adopting these technologies, supported by a growing number of healthcare facilities. The competitive landscape is characterized by a mix of local and international players, with companies like W. L. Gore & Associates making strides in the market. As healthcare systems continue to evolve, the demand for heart closure devices is expected to rise, presenting opportunities for growth.

Key Players and Competitive Insights

The heart closure devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Key players such as Abbott (US), Boston Scientific (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Abbott (US) focuses on innovation, particularly in developing minimally invasive devices, while Boston Scientific (US) emphasizes strategic partnerships to expand its product portfolio. Medtronic (US), on the other hand, is investing heavily in digital transformation to streamline operations and improve patient outcomes. Collectively, these strategies contribute to a competitive environment that is increasingly centered around innovation and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a moderately fragmented market. This approach not only enhances operational efficiency but also allows for quicker responses to regional demands. The competitive structure is shaped by the collective influence of these key players, who are leveraging their strengths to capture market share and drive growth.
In November Abbott (US) announced the launch of its latest heart closure device, which incorporates advanced imaging technology to enhance procedural accuracy. This strategic move is significant as it positions Abbott to meet the growing demand for precision in cardiac interventions, potentially increasing its market share in a competitive landscape.
In October Boston Scientific (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its heart closure devices. This collaboration is likely to enhance patient engagement and adherence to treatment protocols, thereby improving overall outcomes and solidifying Boston Scientific's position as a leader in innovative cardiac solutions.
In September Medtronic (US) expanded its manufacturing capabilities in Europe, aiming to increase production efficiency and meet the rising demand for heart closure devices. This expansion is strategically important as it not only reduces lead times but also strengthens Medtronic's supply chain resilience in a competitive market.
As of December current trends in the heart closure devices Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are becoming more prevalent, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on technological advancements, innovation, and supply chain reliability. This transition underscores the importance of developing cutting-edge solutions that address patient needs while ensuring operational excellence.

Key Companies in the Heart Closure Devices Market include

Future Outlook

Heart Closure Devices Market Future Outlook

The heart closure devices market is projected to grow at a 5.37% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Expansion into emerging markets with tailored product offerings. Development of minimally invasive heart closure devices for outpatient procedures. Strategic partnerships with healthcare providers for integrated care solutions.

By 2035, the heart closure devices market is expected to be robust, driven by innovation and strategic growth initiatives.

Market Segmentation

heart-closure-devices-market End User Outlook

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutions

heart-closure-devices-market Material Outlook

  • Metal
  • Polymer
  • Biodegradable Materials
  • Composite Materials
  • Ceramics

heart-closure-devices-market Technology Outlook

  • Minimally Invasive Techniques
  • Robotic Surgery
  • 3D Imaging
  • Ultrasound Guidance
  • Electrophysiology

heart-closure-devices-market Application Outlook

  • Atrial Septal Defect
  • Patent Foramen Ovale
  • Ventricular Septal Defect
  • Left Atrial Appendage Closure
  • Congenital Heart Defects

heart-closure-devices-market Device Type Outlook

  • Transcatheter Closure Devices
  • Surgical Closure Devices
  • Occluders
  • Patches
  • Stents

Report Scope

MARKET SIZE 2024 4.5(USD Billion)
MARKET SIZE 2025 4.74(USD Billion)
MARKET SIZE 2035 8.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.37% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Abbott (US), Boston Scientific (US), Medtronic (US), Edwards Lifesciences (US), Terumo Corporation (JP), LivaNova (GB), AtriCure (US), Cardia (US), W. L. Gore & Associates (US)
Segments Covered Application, Device Type, End User, Material, Technology
Key Market Opportunities Advancements in minimally invasive techniques enhance growth potential in the heart closure devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the heart closure devices market.
Countries Covered North America, Europe, APAC, South America, MEA
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Garvit Vyas LinkedIn
Vice President - Operations
Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.
Get In Touch
Leave a Comment

FAQs

What is the projected market valuation for heart closure devices by 2035?

<p>The heart closure devices market is projected to reach a valuation of 8.0 USD Billion by 2035.</p>

What was the market valuation for heart closure devices in 2024?

<p>In 2024, the heart closure devices market was valued at 4.5 USD Billion.</p>

What is the expected CAGR for the heart closure devices market during the forecast period 2025 - 2035?

<p>The expected CAGR for the heart closure devices market during the forecast period 2025 - 2035 is 5.37%.</p>

Which companies are considered key players in the heart closure devices market?

<p>Key players in the heart closure devices market include Abbott, Boston Scientific, Medtronic, Edwards Lifesciences, and Terumo Corporation.</p>

What are the primary applications of heart closure devices?

<p>The primary applications of heart closure devices include Atrial Septal Defect, Patent Foramen Ovale, and Ventricular Septal Defect.</p>

How does the market for transcatheter closure devices compare to surgical closure devices?

<p>The market for transcatheter closure devices was valued at 1.5 USD Billion in 2024 and is projected to reach 2.5 USD Billion, whereas surgical closure devices were valued at 1.0 USD Billion and are expected to grow to 1.8 USD Billion.</p>

What is the anticipated growth in the hospital segment for heart closure devices by 2035?

<p>The hospital segment for heart closure devices is expected to grow from 1.8 USD Billion in 2024 to 3.2 USD Billion by 2035.</p>

What materials are predominantly used in heart closure devices?

<p>Predominantly used materials in heart closure devices include metal, polymer, and biodegradable materials, with metal projected to grow from 1.5 USD Billion to 2.5 USD Billion.</p>

What technological advancements are influencing the heart closure devices market?

<p>Technological advancements such as minimally invasive techniques and robotic surgery are influencing the heart closure devices market, with minimally invasive techniques expected to grow from 1.5 USD Billion to 2.5 USD Billion.</p>

What is the projected market size for occluders in the heart closure devices market?

<p>The projected market size for occluders in the heart closure devices market is expected to increase from 1.2 USD Billion in 2024 to 2.0 USD Billion by 2035.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓